Case Report

Secondary Skin Hyperpigmentation During with Peginterferon Alpha and Ribavirin Treatment for Chronic Hepatitis C Virus Infection: Case Report

Havva Yıldız Seçkin^1*, Akgül Arıcı², Yalçın Baş¹, Zennure Takçı¹, Sercan Sezgin¹

¹ Gaziosmanpasa University, School of Medicine, Department of Dermatology

² Department of Pathology, Tokat

Anahtar Kelimeler: HCV infectionhyperpigmentationpeginterferonalpha-2a

Keywords: HCV infectionhyperpigmentationpeginterferonalpha-2a

TR PDF İndir

Abstract

ABSTRACT

Observation:

Interferon-alpha (INF) or peginterferon alpha (PEG IFN) and ribavirin combination therapy in chronic hepatitis C virus (HCV) infection is recognized as an effective treatment method. Skin related side effects have rarely been reported during chronic HCV infection treatments and they usually are lesions seen in the local injection sites. We present a case with HCV infection that occurred in the sun-exposed areas and axillar area by secondary pigmentation during PEG-INF-2a plus and ribavirin combination therapy.